Stock & Company Details
Fennec Pharmaceuticals Inc $FENC
Price:
N/A
N/A
35M
$373M
52 Week High:
N/A
10 Day Average Volume:
N/A
-37.34
50 Day Moving Average:
N/A
52 Week Low:
N/A
30 Day Average Volume:
N/A
N/A
N/A
N/A
30 Day Change:
N/A
3 Month Change:
N/A
Health Technology
FENC technical indicators
Latest Fennec Pharmaceuticals Inc (FENC) indicator readings as of 2026-10-09.
FENC's 14-day RSI is 48.1, in neutral territory. At $10.71 it is trading 19.0% above its 200-day moving average of $9.00, and below its 50-day average of $11.19. Price sits in the middle of its Bollinger Bands ($10.22 to $11.04). ADX reads 26.5, indicating a trending market.
Overview
Fennec Pharmaceuticals Inc is a clinical-stage biotechnology company. It is engaged in research and development activities. The company is developing Sodium Thiosulfate (STS), a chemo-protectant against hearing loss associated with platinum-based chemotherapy. Its product candidate is PEDMARK which is sodium thiosulfate in a novel formulation for the prevention of cisplatin induced hearing loss, or ototoxicity in children. The company principally operates in the United States.
Finance Bot
Ask your questions
Start by typing a question below.
